Skip to main content
Caplight Logo









Help Therapeutics

Help Therapeutics

Private
NanjingHealthcare & Life Scienceshttps://helptherapeutics.com/

Last Round

Series C

Nov 15, 2021

Total Funding Raised

$35.51M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Help Therapeutics is a biotechnology company that develops induced-pluripotent stem cell (iPSC) and mesenchymal stem cell (MSC) technology to treat degenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

cell therapyiPSCinduced pluripotent stem cellregenerative medicineautomated cell manufacturingbiomanufacturingoff-the-shelf therapyallogeneic cell therapybiotech lab automationstem cell bankcardiomyocyte injectionbiorepositoryclinical-stage biopharmalab-grown tissueai in biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Help Therapeutics Comparables

Compare Help Therapeutics with similar companies based on industry and business-model similarity.

Help Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Heartseed
89%
Bayer AG
82%
iHeart Japan Corporation
79%

Help Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 15, 2021
Series A ExtensionOct 15, 2020
Series AJun 1, 2016

Help Therapeutics Investors

Notable investors and investment history

Help Therapeutics investors
InvestorRounds
Oriental Fortune CapitalSeries A, Angel
Legend StarSeries A Extension, Series A, Angel
Ming BioventuresSeries C
Jinmao CapitalSeries C
Share CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 119% MoM, from 646 to 1.4K.

  • Jun 3, 2026

    Headcount grew 24% QoQ (from 21 to 26 employees)

Help Therapeutics Filings

Explore SEC and related filing metadata, where available.

Help Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Help Therapeutics's valuation, stock price, and market status.

Is Help Therapeutics a public or private company?

Help Therapeutics is a private company.

What is the current stock price of Help Therapeutics?

Help Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Help Therapeutics worth (valuation)?

Valuation information for Help Therapeutics is not publicly available.

Can I buy Help Therapeutics stock?

Help Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Help Therapeutics's last funding round?

Help Therapeutics's most recent funding round was Series C on November 15, 2021.

Who are the main investors in Help Therapeutics?

Key investors in Help Therapeutics include Ming Bioventures.

Will Help Therapeutics IPO soon?

No public IPO plans have been announced for Help Therapeutics.

How can I track Help Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Help Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNanjing
Employee Range25
Year Founded2016
Last FundingNov 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?